Department of Gastroenterology & Hepatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Jiefang Avenue 1095#, Wuhan City, Hubei Province, 430030, China.
Department of Gastroenterology & Hepatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Jiefang Avenue 1095#, Wuhan City, Hubei Province, 430030, China.
J Ethnopharmacol. 2024 Jan 30;319(Pt 3):117316. doi: 10.1016/j.jep.2023.117316. Epub 2023 Oct 17.
Currently, the clinical treatment is limited and difficult to achieve satisfactory results for ulcerative colitis (UC). The role of traditional Chinese medicine (TCM) in the treatment of UC is very complex. Kuijie decoction (KJD) as a classic TCM, is widely used in the clinical treatment of UC, but the mechanism of its action is still unclear.
This study is to investigate the protective effects of KJD on UC and the underlying mechanisms.
The experimental model of UC was induced by DSS, and KJD was introduced into the model at the same time. Clinical symptoms, including the body weight, colon length and colon histopathological, were used to measure the severity of colitis. The expression of inflammatory cytokines and tight junction proteins was quantified. The effect of KJD on intestinal flora and intestinal metabolism was determined by 16S rRNA and untargeted metabolomics analysis, respectively. The proportion of Th17 cells and Tregs in the spleen was examined by flow cytometry.
Mice treated with KJD showed significantly alleviated clinical symptoms and histological damage, such as more body weight gain, lower disease activity index (DAI) score, and longer colon length. The administration of KJD also led to the down-regulation of inflammatory mediators, upregulation of the expression of ZO-1, occludin and decreased claudin-2, as well as altered microbiota composition against DSS challenges (especially an increase of Lachnospiraceae). KJD enhanced the percentage of Treg cells but decreased the proportion of Th17 cells to maintain intestinal homeostasis by improving gut microbiota metabolism.
In summary, KJD maintained intestinal epithelial homeostasis by regulating epithelial barrier function, intestinal flora, and restoring Th17/Treg balance. KJD has the potential to be a Chinese medicine treatment for UC.
目前,溃疡性结肠炎(UC)的临床治疗方法有限,难以取得满意的效果。中药(TCM)在 UC 治疗中的作用非常复杂。溃结方(KJD)作为一种经典的 TCM,广泛应用于 UC 的临床治疗,但作用机制尚不清楚。
本研究旨在探讨 KJD 对 UC 的保护作用及其作用机制。
采用 DSS 诱导 UC 实验模型,同时引入 KJD。采用临床症状(包括体重、结肠长度和结肠组织病理学)来衡量结肠炎的严重程度。定量检测炎症细胞因子和紧密连接蛋白的表达。通过 16S rRNA 和非靶向代谢组学分析分别检测 KJD 对肠道菌群和肠道代谢的影响。采用流式细胞术检测脾中 Th17 细胞和 Tregs 的比例。
用 KJD 处理的小鼠表现出明显的临床症状和组织学损伤缓解,如体重增加更多、疾病活动指数(DAI)评分更低、结肠长度更长。KJD 的给药还导致炎症介质下调,ZO-1、occludin 表达上调,claudin-2 下调,以及肠道微生物群落组成对 DSS 挑战的改变(特别是lachnospiraceae 的增加)。KJD 通过改善肠道微生物群代谢,增强 Treg 细胞的比例,降低 Th17 细胞的比例,从而维持肠道内稳态。
综上所述,KJD 通过调节上皮屏障功能、肠道菌群和恢复 Th17/Treg 平衡来维持肠道上皮内稳态。KJD 有可能成为治疗 UC 的中药。